(Q39851416)

15 September 2017

title

Effect of compound plate composition on measurement of hERG current IC(50) using PatchXpress (English)

1 reference

15 September 2017

Zun-Li Mo

1

1 reference

15 September 2017

Tracy Faxel

2

1 reference

15 September 2017

Young-Sun Yang

3

1 reference

15 September 2017

Robert Gallavan

4

1 reference

15 September 2017

Dean Messing

5

1 reference

15 September 2017

Anthony Bahinski

6

1 reference

15 September 2017

publication date

13 May 2009

1 reference

Journal of Pharmacological and Toxicological Methods

15 September 2017

published in

1 reference

15 September 2017

volume

60

1 reference

15 September 2017

issue

1

1 reference

15 September 2017

page(s)

39-44

1 reference

A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2009.04.198

Safety of non-antiarrhythmic drugs that prolong the QT interval or induce torsade de pointes: an overview

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2009.04.198

Identifying modulators of hERG channel activity using the PatchXpress planar patch clamp

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2009.04.198

Utility of hERG assays as surrogate markers of delayed cardiac repolarization and QT safety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2009.04.198

Automated electrophysiology in the preclinical evaluation of drugs for potential QT prolongation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2009.04.198

QPatch: the past, present and future of automated patch clamp

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2009.04.198

Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2009.04.198

HERG, a primary human ventricular target of the nonsedating antihistamine terfenadine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2009.04.198

Cardiac electrophysiological actions of the histamine H1-receptor antagonists astemizole and terfenadine compared with chlorpheniramine and pyrilamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2009.04.198

A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2009.04.198

Dependence of molecular properties on proteomic family for marketed oral drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2009.04.198

Troubleshooting problems with in vitro screening of drugs for QT interval prolongation using HERG K+ channels expressed in mammalian cell lines and Xenopus oocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2009.04.198

Properties of HERG channels stably expressed in HEK 293 cells studied at physiological temperature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2009.04.198

10.1016/J.VASCN.2009.04.198

7 January 2021

Identifiers

DOI

1 reference

15 September 2017

1 reference